Jefferies Downgrades Amedisys (AMED) to Hold
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Jefferies downgraded Amedisys (NASDAQ: AMED) from Buy to Hold and lowers their price target from $45 to $29.
The firm cited, "... our belief that ongoing reimbursement risk will provide a continued overhang on the sector that will keep investors on the sidelines until reimbursement visibility improves."
For more ratings news on Amedisys click here and for the rating history of Amedisys click here.
Shares of Amedisys closed at $26.42 yesterday.
The firm cited, "... our belief that ongoing reimbursement risk will provide a continued overhang on the sector that will keep investors on the sidelines until reimbursement visibility improves."
For more ratings news on Amedisys click here and for the rating history of Amedisys click here.
Shares of Amedisys closed at $26.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades StandardAero Inc (SARO) to Hold, 'Softer Backdrop Brings Softer Multiples'
- Oppenheimer Downgrades AT&T (T) to Perform, 'Broadband Subscribers Are at Risk from Satellite Competition'
- Hovde Group Downgrades Carter Bank & Trust (CARE) to Market Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
